Antônio Barbieri
Impact in
- Molecular Medicine top 2%
- Curcumin's Biomedical Applications
- Oncology top 5%
- Cancer Immunotherapy and Biomarkers
- Chemokine receptors and signaling
Papers in
- Oncology 48
- Peptidase Inhibition and Analysis 11
- Cancer Immunotherapy and Biomarkers 10
- Chemokine receptors and signaling 8
- Co-authors
- Claudio Arra (62 shared papers)Giuseppe Palma (33 shared papers)Domenica Rea (31 shared papers)Sabrina Bimonte (28 shared papers)Antonio Luciano (27 shared papers)Nicola Maurea (18 shared papers)Gerardo Botti (16 shared papers)Vincenzo Quagliariello (5 shared papers)
- Journals
- BioMed Research International (5 papers)OncoTargets and Therapy (4 papers)Oncotarget (4 papers)Cell Death and Disease (4 papers)Frontiers in Immunology (3 papers)
- Partner nations
- ItalyUnited StatesBrazil
In The Last Decade
Antônio Barbieri
118 papers receiving 3.7k citations
Antônio Barbieri's Hit Papers
Peers
Comparison fields: 5 of 136
- Molecular Medicine 196
- Oncology 951
- Cancer Research 455
- Complementary and alternative medicine 192
- Molecular Biology 1.4k
Countries citing papers authored by Antônio Barbieri
This map shows the geographic impact of Antônio Barbieri's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Antônio Barbieri with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Antônio Barbieri more than expected).
Fields of papers citing papers by Antônio Barbieri
This network shows the impact of papers produced by Antônio Barbieri. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Antônio Barbieri. The network helps show where Antônio Barbieri may publish in the future.
Co-authors
The 25 scholars most cited alongside Antônio Barbieri, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 122 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | The SGLT-2 inhibitor empagliflozin improves myocardial strain, reduces cardiac fibrosis and pro-inflammatory cytokines in non-diabetic mice treated with doxorubicin Hit paper breakdown → | 2021 | 268 |
| 2 | 2018 | 160 | |
| 3 | 2018 | 150 | |
| 4 | 2017 | 108 | |
| 5 | 2016 | 107 | |
| 6 | 2015 | 97 | |
| 7 | 2013 | 96 | |
| 8 | 2013 | 90 | |
| 9 | 2007 | 86 | |
| 10 | 2019 | 81 | |
| 11 | 2015 | 77 | |
| 12 | 2013 | 76 | |
| 13 | 2015 | 73 | |
| 14 | 2001 | 70 | |
| 15 | 2008 | 68 | |
| 16 | 2018 | 66 | |
| 17 | 2003 | 59 | |
| 18 | 2020 | 57 | |
| 19 | 2017 | 54 | |
| 20 | 2014 | 53 |
About Antônio Barbieri
Antônio Barbieri is a scholar working on Oncology, Molecular Biology, Pulmonary and Respiratory Medicine, Psychiatry and Mental health and Immunology, having authored 122 papers that have together received 3.7k indexed citations. Recurring topics across this work include Immunotherapy and Immune Responses (13 papers), Cancer, Stress, Anesthesia, and Immune Response (12 papers), Peptidase Inhibition and Analysis (11 papers), Chemotherapy-induced cardiotoxicity and mitigation (11 papers), Cancer Immunotherapy and Biomarkers (10 papers), Chemokine receptors and signaling (8 papers), Neuropeptides and Animal Physiology (7 papers) and Nanoplatforms for cancer theranostics (6 papers). The work is most often cited by research in Molecular Medicine (196 citations), Oncology (951 citations), Cancer Research (455 citations), Complementary and alternative medicine (192 citations) and Molecular Biology (1.4k citations). Antônio Barbieri has collaborated with scholars based in Italy, United States and Brazil. Frequent co-authors include Claudio Arra, Giuseppe Palma, Domenica Rea, Sabrina Bimonte, Antonio Luciano, Nicola Maurea, Gerardo Botti, Vincenzo Quagliariello, Arturo Cuomo and Vitale Del Vecchio. Their work appears in journals such as BioMed Research International, OncoTargets and Therapy, Oncotarget, Cell Death and Disease and Frontiers in Immunology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.